- Home
- BRTX vs FLGC Comparison
BRTX vs FLGC Comparison
Compare BRTX & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- FLGC
- Stock Information
- Founded
- BRTX 1997
- FLGC 2019
- Country
- BRTX United States
- FLGC United States
- Employees
- BRTX 11
- FLGC N/A
- Industry
- BRTX Managed Health Care
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- BRTX Health Care
- FLGC Health Care
- Exchange
- BRTX Nasdaq
- FLGC Nasdaq
- Market Cap
- BRTX 13.7M
- FLGC 11.7M
- IPO Year
- BRTX N/A
- FLGC 2021
- Fundamental
- Price
- BRTX $1.67
- FLGC $0.66
- Analyst Decision
- BRTX Strong Buy
- FLGC Strong Buy
- Analyst Count
- BRTX 1
- FLGC 3
- Target Price
- BRTX $18.00
- FLGC $5.00
- AVG Volume (30 Days)
- BRTX 27.4K
- FLGC 289.8K
- Earning Date
- BRTX 05-14-2025
- FLGC 05-13-2025
- Dividend Yield
- BRTX N/A
- FLGC N/A
- EPS Growth
- BRTX N/A
- FLGC N/A
- EPS
- BRTX N/A
- FLGC N/A
- Revenue
- BRTX $401,000.00
- FLGC $53,260,000.00
- Revenue This Year
- BRTX $446.88
- FLGC $2.33
- Revenue Next Year
- BRTX $39.53
- FLGC N/A
- P/E Ratio
- BRTX N/A
- FLGC N/A
- Revenue Growth
- BRTX 175.03
- FLGC N/A
- 52 Week Low
- BRTX $1.03
- FLGC $0.42
- 52 Week High
- BRTX $2.55
- FLGC $2.11
- Technical
- Relative Strength Index (RSI)
- BRTX 41.86
- FLGC 54.99
- Support Level
- BRTX $1.66
- FLGC $0.50
- Resistance Level
- BRTX $1.88
- FLGC $0.75
- Average True Range (ATR)
- BRTX 0.08
- FLGC 0.07
- MACD
- BRTX -0.01
- FLGC 0.01
- Stochastic Oscillator
- BRTX 8.33
- FLGC 63.16
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.